Subacute Liver Failure Following Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
We report 2 cases of transient, drug-induced liver failure after this therapy.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Amy G. Feldman, Julie A. Parsons, Cullen M. Dutmer, Aravindhan Veerapandiyan, Einar Hafberg, Nolan Maloney, Cara L. Mack Tags: Brief Reports Source Type: research
More News: Adenoviruses | Brain | Food and Drug Administration (FDA) | Genetics | Liver | Motor Neurone Disease | Neurology | Pediatrics | Spinal Muscular Atrophy | Urology & Nephrology